Zobrazeno 1 - 10
of 153
pro vyhledávání: '"E. E. Moran"'
Autor:
S. Biggs-Cicatelli, Robert Burden, James E. Moon, James F. Cummings, E. E. Moran, Wendell D. Zollinger, Paul B. Keiser, Deborah H. Schmiel, Lori Miller, Valerian B. Pinto, Robert A. Bowden
Publikováno v:
Vaccine. 29:1413-1420
This phase I clinical trial assessed the safety and immunogenicity of a native outer membrane vesicle (NOMV) vaccine prepared from an lpxL1(-) synX(-) mutant of strain 8570(B:4:P1.19,15:L8-5) of Neisseria meningitidis. Additional mutations enhance th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7c2225c7e0b9d8f50e18a53eba584c
https://doi.org/10.1016/j.vaccine.2010.12.039
https://doi.org/10.1016/j.vaccine.2010.12.039
Autor:
Valerian B. Pinto, Paul B. Keiser, Mark B. Stoddard, Ping Chen, Wendell D. Zollinger, Joseph E. Labrie, Deborah H. Schmiel, E. E. Moran, Trinka S. Coster, Barnett Gibbs
Publikováno v:
Vaccine. 28:6970-6976
This phase 1 clinical trial assessed the safety and immunogenicity of a native outer membrane vesicle (NOMV) vaccine prepared from a lpxL2(-) synX(-) mutant of strain 44/76 with opcA expression stabilized. Thirty-four volunteers were assigned to one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::074262d6db3881b7aca66152f68a3a8d
https://doi.org/10.1016/j.vaccine.2010.08.048
https://doi.org/10.1016/j.vaccine.2010.08.048
Autor:
Victor Agnello, Stephen Marks, Brenda L. Brandt, Wendell D. Zollinger, E. E. Moran, Rohit K. Katial
Publikováno v:
Infection and Immunity. 70:702-707
The presently licensed meningococcal vaccine is a tetravalent capsular polysaccharide vaccine that induces immunity to serogroups A, C, Y, and W-135 but not to group B, which causes nearly half of the meningitis cases in the United States. The purpos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c771b4d3bae7553114208c38312515
https://doi.org/10.1128/iai.70.2.702-707.2002
https://doi.org/10.1128/iai.70.2.702-707.2002
Autor:
Wendell D. Zollinger, Nancy B. Saunders, E. E. Moran, David R. Shoemaker, Thomas Larsen, Brenda L. Brandt
Publikováno v:
Infection and Immunity. 67:113-119
Colonization of the human nasopharyngeal region by Neisseria meningitidis is believed to lead to natural immunity. Although the presence of bactericidal antibody in serum has been correlated with immunity to meningococcal disease, mucosal immunity at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe2d2d0e6d7a7c30bcda964f3722ea98
https://doi.org/10.1128/iai.67.1.113-119.1999
https://doi.org/10.1128/iai.67.1.113-119.1999
Autor:
Janet S. Foster, Wendell D. Zollinger, Douglas B. Tang, E. E. Moran, Andrew F. Trofa, Joseph J. Drabick
Publikováno v:
Vaccine. 15:1144-1148
Cimetidine (CIM) is an H2-receptor antagonist with a long history of clinical use in peptic ulcer disease. In addition to its inhibitory effect upon gastric acid secretion, CIM can also block histamine-mediated immunosuppression by inhibiting H2 rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13830e673962487823c61a6e975eeca
https://doi.org/10.1016/s0264-410x(96)00311-8
https://doi.org/10.1016/s0264-410x(96)00311-8
Publikováno v:
Infection and Immunity. 65:1053-1060
Reports on the bactericidal activities of antibodies to group B Neisseria meningitidis capsular polysaccharide (B PS) are conflicting. Using three different complement sources, we analyzed the bactericidal activities of sera of juvenile rhesus monkey
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8904d180744bc4860862586e8deb4bc4
https://doi.org/10.1128/iai.65.3.1053-1060.1997
https://doi.org/10.1128/iai.65.3.1053-1060.1997
Publikováno v:
Infection and Immunity. 62:5290-5295
The influence of lipopolysaccharide (LPS) expression on the sensitivity of Neisseria meningitidis to serum bactericidal activity was investigated by using a series of variants that expressed different LPS determinants. For each of two different strai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c4d7419b3a5bab10f7c798e405f098
https://doi.org/10.1128/iai.62.12.5290-5295.1994
https://doi.org/10.1128/iai.62.12.5290-5295.1994
Autor:
Wendell D. Zollinger, E. E. Moran
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 85
Over 20 years after the development of the meningococcal A and C vaccines, an effective vaccine against Neisseria meningitidis group B is still lacking. Major obstacles in the development of a B vaccine have been the remarkable capacity of the organi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d13aafc7eab3fb6a726597f6f5c696d
https://pubmed.ncbi.nlm.nih.gov/1803695
https://pubmed.ncbi.nlm.nih.gov/1803695
Autor:
Brenda L. Brandt, L. O. FrØholm, J. S. Ray, E. E. Moran, Wendell D. Zollinger, John W. Boslego
Publikováno v:
Antonie van Leeuwenhoek. 53:403-411
Several different meningococcal outer membrane protein vaccines have been prepared and used in human safety and immunogenicity studies. The results of these studies have led to some general conclusions regarding the human antibody response to these v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b406dea2b3f51d3d68b99cde86c685
https://doi.org/10.1007/bf00415494
https://doi.org/10.1007/bf00415494
Publikováno v:
Antonie van Leeuwenhoek. 52:225-228
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::859db979020fbaeafc738119841ff00e
https://doi.org/10.1007/bf00555240
https://doi.org/10.1007/bf00555240